Literature DB >> 7718642

Pulmonary fungal infections in patients with hematological malignancies--diagnostic approaches.

M von Eiff1, M Zühlsdorf, N Roos, M Hesse, R Schulten, J van de Loo.   

Abstract

In a retrospective study of 56 patients with hematological malignancies and fungal pneumonia we have analyzed the value of different diagnostic procedures. In all patients (Candida n = 29, Aspergillus n = 23, mixed fungal infection n = 4) bronchoscopy and/or high-resolution computed tomography of the lungs was performed. Cultural detection of fungi in bronchoalveolar lavage was successful in 23/32 Candida and 11/23 Aspergillus pneumonias. Other relevant pathogens were identified by bronchoscopy in 21 cases. Thorax CT scans showed diagnostic evidence of fungal pneumonia in 10/13 Candida and in 16/18 Aspergillus infections. Blood cultures were positive in 9/33 Candida pneumonias and in none of aspergillosis cases. Serological testing and surveillance cultures had only limited value for the early diagnosis of pulmonary mycosis. Our data suggest that bronchoscopy and high resolution CT scans are mutually complementary diagnostic tools with high sensitivity in patients with hematological malignancies and new pulmonary infiltrates. These procedures facilitate the early and reliable recognition of invasive fungal disease which may have a bearing on the initiation, length, and differential therapy of antimycotic drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7718642     DOI: 10.1007/bf01682033

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  29 in total

Review 1.  Problems in management of opportunistic fungal diseases.

Authors:  D Armstrong
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

2.  CT findings in fungal opportunistic pneumonias: body and brain involvement.

Authors:  G Potente
Journal:  Comput Med Imaging Graph       Date:  1989 Sep-Oct       Impact factor: 4.790

3.  Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S M Albelda; G H Talbot; S L Gerson; W T Miller; P A Cassileth
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

Review 4.  Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.

Authors:  E Anaissie
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

5.  [Pneumonia in immunocompromised patients: the value of non-biopsy bronchoscopic examination procedures in the diagnosis of pathogens].

Authors:  M von Eiff; R Steimann; N Roos; N van Husen; P Walger; P Baumgart; W Fegeler; E Junge; H Baumeister; B Wilms
Journal:  Klin Wochenschr       Date:  1990-04-02

6.  Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study.

Authors:  C S Pannuti; R D Gingrich; M A Pfaller; R P Wenzel
Journal:  J Clin Oncol       Date:  1991-01       Impact factor: 44.544

7.  Opportunistic fungal pneumonias in cancer patients.

Authors:  J J Pagani; H I Libshitz
Journal:  AJR Am J Roentgenol       Date:  1981-11       Impact factor: 3.959

8.  Pulmonary candidiasis in infants: clinical, radiologic, and pathologic features.

Authors:  E G Kassner; S L Kauffman; J J Yoon; M Semiglia; P J Kozinn; P L Goldberg
Journal:  AJR Am J Roentgenol       Date:  1981-10       Impact factor: 3.959

9.  Nosocomial fungemia in a large community teaching hospital.

Authors:  R L Harvey; J P Myers
Journal:  Arch Intern Med       Date:  1987-12

10.  [Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients].

Authors:  B Pfaffenbach; K Donhuijsen; J Pahnke; R Bug; R J Adamek; M Wegener; D Ricken
Journal:  Med Klin (Munich)       Date:  1994-06-15
View more
  7 in total

1.  Postmortem analysis of invasive aspergillosis in a tertiary care hospital.

Authors:  M Vogeser; A Haas; D Aust; G Ruckdeschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

2.  Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR.

Authors:  H Skladny; D Buchheidt; C Baust; F Krieg-Schneider; W Seifarth; C Leib-Mösch; R Hehlmann
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 3.  The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.

Authors:  Sarah P Georgiadou; Nikolaos V Sipsas; Edith M Marom; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

4.  Improved outcomes associated with limiting identification of Candida spp. in respiratory secretions.

Authors:  Joan Barenfanger; Pushpalatha Arakere; Rafael Dela Cruz; Adil Imran; Cheryl Drake; Jerry Lawhorn; Steven J Verhulst; Nancy Khardori
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  Central nervous system Aspergillus fumigatus infection after near drowning.

Authors:  P A Kowacs; S Monteiro de Almeida; R L Pinheiro; H Fameli; E J Piovesan; A Correia; L C Werneck
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 6.  [Lung involvement in hematologic systemic diseases].

Authors:  S-S Stecher; S Lippl; H J Stemmler; J Schreiber
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

7.  Two Monoclonal Antibodies That Specifically Recognize Aspergillus Cell Wall Antigens and Can Detect Circulating Antigens in Infected Mice.

Authors:  Xihua Lian; Stephen Chambers; John G Lewis; Amy Scott-Thomas; Madhav Bhatia
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.